CRWD vs ORCL: Which Is the Better Buy?

Side-by-side comparison of CrowdStrike Holdings, Inc. and Oracle Corporation โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-22.
CrowdStrike Holdings, Inc. ยท Technology
$449.61
+106.1% upside to fair value
Grade C High Quality
VS
Oracle Corporation ยท Technology
$175.08
+137.3% upside to fair value
Grade C High Quality
QuantHub Verdict
ORCL has more upside to fair value (+137.3%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric CRWD ORCL
Current Price $449.61 $175.08
Fair Value Estimate $926.44 $415.43
Upside to Fair Value +106.1% +137.3%
Market Cap $114.0B $503.5B
Forward P/E -619.9x 30.8x
EV / EBITDA 981.7x 21.4x
Price / Sales 23.7x 7.9x
Price / FCF 92.0x -20.4x
Revenue Growth YoY +23.3% +21.7%
Gross Margin 74.9% 66.4%
Operating Margin -5.4% 30.8%
Return on Equity -4.7% 57.4%
Dividend Yield 0% 0%
FCF Yield 1.09% โ€”
Analyst Consensus Buy Strong Buy
Investment Thesis
CRWD โ€” CrowdStrike Holdings, Inc.
CrowdStrike Holdings, Inc. is a leading cybersecurity company specializing in cloud-native endpoint protection and threat intelligence through its Falcon platform, which generates over 94% of its revenue from subscription services. The business quality is high due to its durable competitive moat built on cutting-edge big data security technology, strong management with a founder-led CEO who has oโ€ฆ
ORCL โ€” Oracle Corporation
Oracle Corporation is a leading enterprise software and cloud infrastructure provider with a strong legacy in database technology and a growing cloud business. The company benefits from a durable competitive moat supported by high insider ownership, experienced leadership, and a history of strategic acquisitions. Oracle's recent financials show robust revenue growth of 21.7% and earnings growth oโ€ฆ
Accumulation Zones
Metric CRWD ORCL
Zone Low $694.83 $311.57
Zone High $787.47 $353.12
In Buy Zone? Yes Yes
โ† CRWD Research    ORCL Research โ†’    All Research